The overall goal of this activity is to enable multidisciplinary clinicians to recognize the distinct biology and clinical behavior of non-HPV associated versus HPV-positive r/m HNSCC, understand how this differentiation impacts current treatment outcomes, and evaluate emerging therapeutic strategies that may improve management of non-HPV associated disease.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- Masdijk 409
Pricing
$54 – $4,128 per course
typical $950 · based on 60 courses listed here
Collected from the provider’s public pages · source
Specialties served/covered
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Critical Care Medicine
- Dermatology
- Diagnostic Radiology
- Emergency Medicine
- Endocrinology, Diabetes & Metabolism
- Evidence-Based Medicine & Research
- Foot & Ankle Surgery
- Gastroenterology
- General Internal Medicine
- General Pediatrics
- Head & Neck Surgery
- Interventional Radiology
- Medical Oncology
- Nephrology
- Neurology
- Neuromuscular Medicine
- Nuclear Medicine
- Obstetrics & Gynecology
- Pediatric Radiology
- Physical Medicine & Rehabilitation
- Pulmonary Disease
- Radiation Oncology
- Rheumatology
- Urological Oncology
- Vascular Neurology
- Vascular Surgery
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- ENT & Head Neck
- GI & Liver
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Orthopedics
- Pediatrics
- Radiology
- Rehabilitation
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Case-based learning
- Credit · Up to 1 credit
- Commercial Support
-
ReleasedMar 17, 2026
-
Last day to claim creditMar 17, 2027 5 months left
-
Clinical Care Options, LLC (dba Decera Clinical Education) Expert Guidance on Navigating the Evolving Head and Neck Cancer Treatment Continuum: What Matters Now and How to Apply It in Practice
-
PVI, PeerView Institute for Medical Education Definitive Innovation in Resectable Head and Neck Cancer: New Immunotherapy Approaches in LA-HNSCC
-
American Academy of Otolaryngology – Head & Neck Surgery Foundation Beyond the Battle: Life After Head and Neck Cancer and the Vital Role of Survivorship (2024 AMW)
-
PeerVoice, Siyemi Europe Limited PeerVoice – Testing. Targeting. Transforming: Practical Guidance for the Management of HER2-Positive Gastrointestinal Cancers – Enduring
-
PeerVoice, Siyemi Europe Limited PeerVoice – Translating Evidence Into Individualized Decisions Across the Spectrum of SCLC: Expert Insights on Contemporary Cases
-
PeerVoice, Siyemi Europe Limited PeerVoice – Hope is on the Horizon: Anticipating Novel Treatment Approaches in Advanced Pancreatic Cancer
